A Phase II Single-centre Study of IBsolvMIR (dextran sulfate-low molecular weight) in auto-islet Transplant for Patients With Chronic Pancreatitis

Trial Profile

A Phase II Single-centre Study of IBsolvMIR (dextran sulfate-low molecular weight) in auto-islet Transplant for Patients With Chronic Pancreatitis

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Dextran sulfate (Primary)
  • Indications Pancreas transplant rejection
  • Focus Therapeutic Use
  • Sponsors TikoMed
  • Most Recent Events

    • 02 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top